Compounded Drug Products That Are Essentially Copies of Approved Drug Products Under Section 503B of the Federal Food, Drug, and Cosmetic Act Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 19, 2018
May 7, 2020
01d6567b-d27c-4dc3-b329-01ed5a29bb89
Related Documents
Repackaging of Certain Human Drug Products by Pharmacies and Outsourcing Facilities: Guidance for Industry
Guidance DocumentJanuary 13, 2017Center for Drug Evaluation and Research
Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry
Guidance DocumentJanuary 19, 2018Center for Drug Evaluation and Research
Pharmacy Compounding of Human Drug Products Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance
Guidance DocumentJuly 2, 2014Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox